A team of researchers from Finland and Norway has identified two potential antivirulence compounds for enteropathogenic Escherichia coli (EPEC) infections among bacterial metabolites harvested from strains of marine actinobacteria Kocuria and Rhodococcus from the Arctic Sea. The T091-5 strain of the genus Rhodococcus. Image credit: Pylkkö et al., doi: 10.3389/fmicb.2024.1432475. “We show how advanced screening assays can identify antivirulence...
